IVVD Invivyd, Inc.
Healthcare$1.10+0.00%ClosedMarket Cap: $146.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.68
P/S
2.61
EV/EBITDA
0.37
DCF Value
$11.22
FCF Yield
-54.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
92.0%
Operating Margin
-146.4%
Net Margin
-138.9%
ROE
-53.5%
ROA
-32.1%
ROIC
-38.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $13.7M | 88.8% | $-43.1M | $-41.4M | $— | — |
| Q4 null | $17.2M | 93.4% | $-12.6M | $-11.1M | $— | — |
| FY null | $53.4M | 93.0% | $-55.6M | $-52.5M | $— | — |
| Q3 null | $13.1M | 91.7% | $-11.0M | $-10.5M | $— | — |
| Q2 null | $11.8M | 94.2% | $-15.1M | $-14.7M | $— | — |
| Q1 null | $11.3M | 92.6% | $-16.9M | $-16.3M | $— | — |
| Q4 null | $13.8M | 94.8% | $-19.2M | $-18.4M | $— | — |
| FY null | $25.4M | 93.6% | $-176.9M | $-169.9M | $— | — |
| Q3 null | $9.3M | 91.3% | $-62.3M | $-60.7M | $— | — |
| Q2 null | $2.3M | 96.1% | $-49.2M | $-47.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-46.1M | $-43.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-76.8M | $-73.7M | $-0.67 | — |